Lacosamide in Preventing Seizures in Participants With Malignant Glioma
Status:
Terminated
Trial end date:
2017-06-20
Target enrollment:
Participant gender:
Summary
This trial studies how well lacosamide works in preventing seizures in participants with
malignant glioma. Anti-seizure drugs, such as lacosamide, may decrease abnormal electrical
activity in the brain that plays a role in developing seizures.
Phase:
N/A
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborators:
Brain Tumor Trials Collaborative National Cancer Institute (NCI) UCB Pharma